The Role of Cancer-associated Fibroblasts in Invasive Behavior of Pituitary Adenoma

ZHONG Chuan-hong, TAO Bei, WU Yao. et al

Abstract

To determine the role of cancer associated fibroblasts (CAFs) in the invasive behavior of pituitary adenoma. Methods Pituitary adenoma tissues were divided into invasive group (IPA) and non-invasive group (nIPA) according to pre-operative MRI and observations during surgery. Those tissues were cultured and CAFs were identified through α smooth muscle actin (α-SMA). The migratory and invasive ability of CAFs was tested with transwell migration and invasion assay. The expressions of α-SMA and matrix metalloproteinase (MMP)-9 from CAFs were determined by immunocytochemistry and Western blot. Results All cultured CAFs expressed α-SMA. No significant difference in migratory ability of CAFs was found between the IPA and nIPA tissues; however, CAFs from the IPA tissues had stronger invasive ability than those from the nIPA tissues ( P=0.010). Higher levels of MMP-9 expression were found in group IPA as compared with nIPA ( P=0.025). No significant difference in the expression of α-SMA was found between the two groups. Conclusion CAFs may promote invasive behavior by secreting more MMP-9, which may play a part in the invasive behavior of pituitary adenomas.

 

Keywords: Cancer-associated fibroblasts, Pituitary adenomas Invasion, MMP-9 

 

Full Text:

PDF


References


Raverot G, Jouanneau E, Trouillas J. Management of endocrine disease; clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies. Eur J Endocrinol, 2014 ; 170(4 ); R121- R132.

Sanchez-Tejada L, Sanchez-Ortiga R, Moreno-Perez (), etui. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness. Endocrinol Nutr, 2013; 60 (7):358-367.

Ezzat S. Epigenetic control in pituitary tumors. Endocr J, 2008;55(6):951-957.

Mete O, Ezzat S, Asa SL. Biomarkers of aggressive pituitary adenomas. J Mol Endocrinol,2012;49(2);R69-R78.

Jia W, Sander AJ, Jia G, et al. Vascular endothelial growth inhibitor ( VEGI) is an independent indicator for invasion in human pituitary adenomas. Anticancer Res, 2013;33(9);3815- 3822.

Ostman A, Augsten M. Cancer-associated fibroblasts and tumor growth bystanders turning into key players. Curr Opin Genet Dev,2009; 19( 1) ;67-73.

Knosp E, Steiner E, Kitz K, et al. Pituitary adenomas with invasion of the cavernous sinus space; a magnetic resonance imaging classification compared with surgical findings. Neurosurgery, 1993 ; 33( 4) ; 610-617.

Wilson CB. A decade of pituitary microsurgery. The Herbert Olivecrona lecture. J Neurosurg. 1984 ;61 (5):814-833.

Catalano V, Turdo A, Di Franco S, et al. Tumor and its microenvironment: a synergistic interplay, Semin Cancer Biol. 2013;23(6 Pt B):522-532.

Guzman-Medrano R. Arreola-Rosales RL, Shibayama M. et al. Tumor-associated macrophages and angiogenesis; a statistical correlation that could reflect a critical relationship in

ameloblastoma. Pathol Res Pract,2012;208( 11):672-676. Onofri C, Theodoropoulou M, Losa M. et al. Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries; detection of a non-endothelial function of VEGF in pituitary tumours. J Endocrinol,2006; 191 (1);249-261.

Roldan ML, Marini PE. First evidence of the interaction between deleted in malignant brain tumor 1 and galectin-3 in the mammalian oviduct. Histochem Cell Biol, 2014; 141 ( 2) : 181-190.

Radosavljevic G, Jovanovic I, Majstorovic I, et al. Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity. Clin Exp Metastasis,2011 ;28(5) ;451-462.

Kelleher FC, Sullivan H, Smyth E. et al. Fibroblast growth factor receptors, developmental corruption and malignant disease. Carcinogenesis,2013;34(10) ;2198-2205.

De Wever О, Van Bockstal M, Mareel M, et al. Carcinoma- associated fibroblasts provide operational flexibility in metastasis. Semin Cancer Biol,2014 ;25; 33-46. doi; 10.1016/ j. semcancer. 2013. 12. 009. Epub 2014 Jan 7.

Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature, 2004 ; 432 ( 7015 ); 332-337.

Bello IO, Vered M, Dayan D, et al. Cancer-associated fibroblasts, a parameter of the tumor microenvironment, overcomes carcinoma-associated parameters in the prognosis of patients with mobile tongue cancer. Oral Oncol, 2011; 47 (1):33-38.

Bainbridge P. Wound healing and the role of fibroblasts. J Wound Care,2013;22(8) :407-408.

Aboussekhra A. Role of cancer-associated fibroblasts in breast cancer development and prognosis. Int J Dev Biol, 2011; 55 ( 7- 9): 841-849.

Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol, 2001; 17:463- 516.

Mueller L, Goumas FA. Affeldt M, et al. Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment. Am J Pathol. 2007;171(5):1608-1618.

Erez N. Glanz S, Raz Y. et al. Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors. Biochem Biophys Res Commun. 2013; 437 ( 3 ); 397- 402.

Mirshafiey A, Asghari B. Ghalamfarsa G, et al. The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosis. Sultan Qaboos Univ Med J ,2014 ; 14(1) ;el3-e25.

Gonzalez-Arriaga P, Pascual T, Garcia-Alvarez A, et al. Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival. BMC Cancer,2012; 12: 121. doi: 10.


Refbacks

  • There are currently no refbacks.